Title21 Health Solutions Voted Top Five Best Places to Work

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
57
Title21 Health Solutions Voted Top Five Best Places to Work

PLEASANTON, Calif., April 26, 2017 (GLOBE NEWSWIRE) -- Title21 Health Solutions, a provider of innovative technology for health sciences was voted among the Top Five Best Places to Work for small businesses in the San Francisco Bay Area.  Over 530 Bay Area companies participated in an independent, third-party survey that asked employees to grade their workplace anonymously on traits such as work culture, team dynamics, benefits, overall compensation, management practices and career development opportunities. Title21 Health Solutions is a leading provider of enterprise quality management software for health science organizations, and in recent years, has gained recognition for its robust software supporting regenerative medicine, blood and marrow transplant, and cellular therapy to improve patient care and outcomes.

Companies that receive this esteemed honor are known for having a healthy culture and a purpose-driven mission that inspires their employees.  “Title21 is a Best Place to Work because our high-functioning, high-performing work culture aligns each employees’ passions with our customers’ objectives,” shares Katie Pizano, who works in Title21 Human Resources.  “Title21 also takes care of its employees with great benefits like the 401k with matched employer contribution and 100% immediate vesting. And of course, our kitchen is well-stocked with the team’s favorite foods and drinks.  We celebrate one another’s contributions and value both learning (aka failures) and successes.”

“Our True North of improving patient care and saving lives is our focus in the work that we do every day to advance healthcare ,” commented Lynn Fischer, CEO of Title21 Health Solutions. “Our integrated enterprise software manages data for hospitals, transplant centers, and regenerative medicine innovators.  Our culture of excellence, empathy, teamwork, transparency, ownership and innovation provides a strong foundation for our team to deliver amazing results for our partners.”

View Title21 Health Solutions’ company profile on the 2017 Best Places to Work List .

About Title21 Health Solutions

Title21 Health Solutions delivers easy-to-use, flexible and integrated technology to support health science organizations to gain efficiencies, enhance compliance and improve patient care.  Title21’s product line includes web-based quality management solutions and the most comprehensive cellular therapy software available on the market.  For a list of Title21’s current open positions, visit Title21.com/Careers.

About 2017 Bay Area Best Places to Work 

Best Places to Work is an innovative publication and awards program produced by the San Francisco Business Times and the Silicon Valley Business Journal.  Rankings are determined by surveys that are distributed directly to employees who answer a series of questions online via Quantum Workplace.  Rankings are based on Quantum’s numeric scoring process, grading employers on categories such as compensation, benefits, work culture, team dynamics, organizational structure, and work/life balance.

Media Contact Haley Roebuck | HaleyR@Title21.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 184

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 341

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 174

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 136

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 300

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading

Top 5 Most Recently Viewed Articles

DoorDash Enters Same-Day Electronics Delivery Market

Updated Category News Views 111

Is DoorDash Changing Its Delivery Playbook? Here's the scoop: DoorDash is venturing into the electronics delivery sector, offering same-day services. We're not talking burgers or late-night sushi anymore—now it's all about those last-minute tech needs like chargers, earbuds, and monitors. It's a smart move, given our reliance on technology to stay connected and...

Continue Reading
Scarlet by RedDrop Earns Esteemed Award for Fundability

Updated Category News Views 251

Scarlet by RedDrop Recognized as a Top Fundable Company Scarlet by RedDrop, a pioneering brand in puberty and period care, has recently achieved a significant milestone. The company has been recognized as one of the Most Fundable Companies by Pepperdine Graziadio Business School, highlighting its impressive growth potential and mission-driven approach. Empowering Young...

Continue Reading
Westpac Predicts RBA's Interest Rate Cuts to Start in May 2025

Updated Category News Views 362

Westpac Forecasts RBA Rate Cuts to Commence in May 2025 According to the latest insights from Westpac, the Reserve Bank of Australia (RBA) is anticipated to start reducing interest rates from May 2025, deviating from prior expectations of an earlier cut in February. This adjustment comes as the central bank is expected to enact significant rate reductions when the easing...

Continue Reading
Innovative Pet Bed Design Revolutionizes Pet Comfort and Play

Updated Category News Views 181

Revolutionizing Pet Comfort with Unique Bed Design In a world where our pets deserve the best, one inventor has taken the initiative to create a pet bed that stands out. The LAY AND PLAY offers a distinctive design tailored especially for cats, ensuring that their needs for play and comfort are met. The inventor explained, “I wanted to invent an alternative pet bed that...

Continue Reading
Lithium Argentina Reveals Q3 2025 Insights and Future Plans

Updated Category News Views 315

Lithium Argentina's Third Quarter Highlights Lithium Argentina AG, a prominent player in the lithium sector, has recently unveiled its third quarter results for 2025. The company, recognized under the ticker symbols TSX: LAR and NYSE: LAR, showcases its ongoing commitment to improving operational performance and efficiency. Webcast and Executive Insights Today's webcast,...

Continue Reading